Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$10.29 USD
-0.05 (-0.48%)
Updated Sep 12, 2024 03:59 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 41 - 60 ( 142 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
3Q23 Beat MD Driven, Best-In-Class CF Drives High Capex Investments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Q323 Results Beat Forecasts, More to Come in 2024 as Multiyear Capex Cycle with $600M Invested Begins to Bear Fruit
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: Ohio Becomes 24th Adult-Use State
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Consumer - Weekly ReHash: 3Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Declining Prices Drives Volume + Illicit Conversion
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: MSO Benchmark Scoring Ahead of 3Q23 Earnings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Industry 3Q23 Insight
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Remains a State Led Growth Story
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Equitization of Debt to Rebalance Balance Seets
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Valuation Expectations Framework
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Returns Sustainable on LT Catalyst Unlocks
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: An Update on Cannabis Capital Raising
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Steady Performance as We Await the Fruits of a Multi-Year Capital Investment Project to Juice Growth
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
2Q23 Steady, Consistent Cash Generation Business, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S